MCC-AAQ-Exa

• Description :

  MCC-AAQ-Exa is a drug-linker conjugates for ADC, obtained by condensing the linker with Exatecan (HY-13631) and can be used to prepare antibody-drug conjugates (ADCs) . MCC is an ADC linker containing a maleimide fragment[1].

• UNSPSC :

  12352203

• Target :

  Drug-Linker Conjugates for ADC

• Related Pathways :

  Antibody-drug Conjugate/ADC Related

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Purity :

  95.33

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  O=C(C1CCC(CC1)CN2C(C=CC2=O)=O)N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H]3C4=C5C(C(N6C5)=CC([C@](O)(C(OC7)=O)CC)=C7C6=O)=NC8=CC(F)=C(C)C(CC3)=C84)=O)=O)=O

• Molecular Formula :

  C47H53FN8O11

• Molecular Weight :

  924.97

• References & Citations :

  [1]Li Hongfeng, et al. Linker drug, and preparation method and use of antibody-drug conjugate thereof. World Intellectual Property Organization, WO2024160176 A1. 2024-08-08.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light, stored under nitrogen)

• Scientific Category :

  ADC Related

• Clinical Information :

  No Development Reported

• CAS Number :

  [3052836-65-1]